Loading Events

Upcoming Events

Events Search and Views Navigation

August 2021

Half-year report 2021 (April-June 2021)

August 19 @ 08:00

Report will be released at 8.00am and conference call at 10.00am CET

Find out more »

September 2021

Pareto Healthcare Conference – 1 September 2021 (Virtual)

September 1

Ascelia Pharma will participate in this conference.

Find out more »

October 2021

Danske Bank Event Series: Life Science, Launch Phase

October 5 @ 11:00 - 11:45

Ascelia Pharma's CEO Magnus Corfitzen will present at Danske Bank Life Science Event Series.

Find out more »

November 2021

Interim report 9M (January-September 2021)

November 4 @ 08:00

Report will be released at 8.00am CET and conference call at 10.00am CET

Find out more »

Danske Bank’s Winter Seminar

November 30 - December 2
IDA Conference Center

Ascelia Pharma’s CEO Magnus Corfitzen will present at Danske Bank's Winter Seminar.  

Find out more »

February 2022

Full year report 2021 (January-December 2021)

2022-02-10 @ 08:00

Report will be released at 8.00am CET and conference call at 10.00am CET

Find out more »
+ Export Events

About us

Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway.

Headquarter is in Malmö, Sweden, and the company’s shares are listed on Nasdaq Stockholm (ticker: ACE)

Download our fact sheet: Ascelia Pharma Factsheet Dec 2020

Events